Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose vs PEG for Overt Hepatic Encephalopathy
NCT03448770Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Aug 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of macrogol in hepatic encephalopathy (HE) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Complete reversal of hepatic encephalopathy in both groups at 3 days. Status: unknown.
02
Drugs
macrogol
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT03448770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03448770.